Agilon Health (NYSE:AGL) Trading Down 9.9% - What's Next?

Key Points

• Agilon Health shares fell 9.9% to about $97.18 despite the company reporting adjusted EPS of $1.04 and revenue of $1.49 billion, both ahead of analyst expectations.
• Management raised its full-year 2026 guidance for revenue, medical margin and adjusted EBITDA, signaling improved confidence in operations and its strategic initiatives.
• The company remains unprofitable, with a negative 6.09% net margin and 146.03% negative return on equity. Analysts maintain a consensus “Hold” rating, with a target price of $73.36.

Agilon Health, Inc. (NYSE:AGL - Get Free Report) shares traded down 9.9% during trading on Thursday . The company traded as low as $87.09 and last traded at $97.1780. 106,539 shares changed hands during trading, a decline of 70% from the average daily volume of 352,914 shares. The stock had previously closed at $107.85.

Agilon Health News Roundup

Here are the key news stories impacting Agilon Health this week:

• Positive Sentiment: Agilon reported adjusted earnings of $1.04 per share, far above the $0.06-$0.14 analyst estimates and a significant improvement from a $6.25-per-share loss a year earlier. Revenue of $1.49 billion also exceeded the roughly $1.45 billion consensus. Agilon Health Tops Q2 Earnings and Revenue Estimates
• Positive Sentiment: Management increased its full-year 2026 guidance for total revenue, medical margin and adjusted EBITDA, signaling greater confidence in operating performance and its strategic initiatives. Agilon Health Reports Second Quarter 2026 Results
• Neutral Sentiment: Additional coverage is examining key operating metrics against Wall Street expectations and year-ago results. Those details may help investors determine whether the quarterly beat reflects durable business improvement or temporary factors. Agilon Q2 Earnings Key Metrics
• Negative Sentiment: Despite the earnings beat, Agilon remains loss-making, with a reported negative net margin of 6.09% and negative return on equity of 146.03%. Investors may therefore be focused on the sustainability and quality of the improvement rather than the headline EPS result alone. Agilon Health Earnings Report

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on AGL shares. Deutsche Bank Aktiengesellschaft upgraded Agilon Health from a "hold" rating to a "buy" rating and raised their price objective for the stock from $33.00 to $49.00 in a research note on Thursday, May 7th. Barclays set a $111.00 price target on shares of Agilon Health and gave the stock an "equal weight" rating in a report on Thursday. Wall Street Zen raised shares of Agilon Health from a "sell" rating to a "hold" rating in a research report on Saturday, May 9th. Jefferies Financial Group upgraded shares of Agilon Health from a "hold" rating to a "buy" rating and lifted their price objective for the company from $27.50 to $48.00 in a research note on Thursday, May 7th. Finally, Truist Financial set a $112.00 price objective on shares of Agilon Health in a report on Thursday. Five investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $73.36.

Agilon Health Stock Down 14.0%

The stock has a market cap of $1.55 billion, a PE ratio of -4.26 and a beta of 3.01. The business has a 50 day moving average price of $106.78 and a 200 day moving average price of $55.26. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.08.

Agilon Health (NYSE:AGL - Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $1.04 earnings per share for the quarter, beating the consensus estimate of $0.14 by $0.90. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%.The company had revenue of $1.49 billion during the quarter, compared to analysts' expectations of $1.45 billion. Equities research analysts expect that Agilon Health, Inc. will post -3.5 EPS for the current fiscal year.

Institutional Trading of Agilon Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. North Peak Capital Management LLC increased its holdings in Agilon Health by 10.8% in the fourth quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company's stock valued at $26,267,000 after buying an additional 3,715,460 shares in the last quarter. Goldman Sachs Group Inc. grew its position in shares of Agilon Health by 196.2% during the 4th quarter. Goldman Sachs Group Inc. now owns 20,055,214 shares of the company's stock valued at $13,812,000 after acquiring an additional 13,283,930 shares during the period. AQR Capital Management LLC grew its position in shares of Agilon Health by 1,346.6% during the 4th quarter. AQR Capital Management LLC now owns 10,211,767 shares of the company's stock valued at $7,033,000 after acquiring an additional 9,505,837 shares during the period. Charles Schwab Investment Management Inc. increased its stake in shares of Agilon Health by 30.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 8,019,002 shares of the company's stock valued at $5,523,000 after purchasing an additional 1,893,434 shares in the last quarter. Finally, Geode Capital Management LLC increased its stake in shares of Agilon Health by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 7,177,477 shares of the company's stock valued at $4,944,000 after purchasing an additional 35,054 shares in the last quarter.

About Agilon Health

Agilon Health NYSE: AGL is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source